Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 6—June 2005

Perspective

Antimicrobial Resistance Determinants and Future Control

Stephan Harbarth*Comments to Author  and Matthew H. Samore†
Author affiliations: *University of Geneva Hospitals, Geneva, Switzerland; †VA Salt Lake City Health Care System, Salt Lake City, Utah, USA

Main Article

Table 3

Proportions of appropriate perioperative antimicrobial drug prophylaxis in Belgian hospitals after change in the reimbursement system*

1986 (%) 1999 (%)
Correct timing 53 70
Correct indication 92 97
Duration >48 h 50 8
Choice of agent
First-generation cephalosporin 28 66
Second-generation cephalosporin 17 29

*Source: Goossens et al (34).

Main Article

TOP